Josh Bloom Archives


Generic Roulette
May 13, 2013 8:41 PM
How can Merck look itself in the mirror?
May 7, 2013 2:20 PM
OxyContin(ues)- The FDA gets it right
April 17, 2013 10:29 PM
Gleevec- The Indian Court Nails it.
April 4, 2013 12:01 PM
MS = Money Sucker?
April 2, 2013 11:03 AM
Maybe the worst paper ever?
March 5, 2013 4:52 PM
Drowning in Morons
February 22, 2013 2:49 PM
When Medicine and Law Enforcement Mix, Patients Lose
January 29, 2013 10:47 AM
Off Label Advice for Doctors- The Appeals Court is Dead On
December 5, 2012 11:22 AM
The New York Times on Drugs
November 30, 2012 10:37 AM
Tami-flu the Coop?
November 27, 2012 9:12 AM
Beta blockers are busted - what happens next?
November 12, 2012 11:54 AM
Red Bull_ _ _ _
October 25, 2012 2:42 PM
Do Vitamins Prevent Cancer? Not So Fast
October 19, 2012 10:32 AM
Abbott Keeps Punishing Hepatitis C
October 16, 2012 4:32 PM
Inderal Indatoilet
October 9, 2012 4:12 PM
B(o)M(b)S away
September 26, 2012 2:00 AM
Interview on HuffPost Live (Chemophobia)
September 13, 2012 1:06 PM
Resistant Bacteria Hit Below the Belt
September 5, 2012 9:46 AM
Cereal Killers
August 22, 2012 11:25 AM
Search
keep in touch     Follow Us on Twitter  Facebook  Facebook

Our Research

Rhetoric and Reality—The Obamacare Evaluation Project: Cost
by Paul Howard, Yevgeniy Feyman, March 2013

Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials
by Avik Roy, April 2012

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
by Tomas J. Philipson, Eric Sun, June 2011

How Conflict-of-Interest Rules Endanger Medical Progress and Cures
by Richard A. Epstein, October 2010

Cost of Caution: The Impact on Patients of Delayed Drug Approvals
by Tomas J. Philipson, Eric Sun, June 2010

In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation
by James R. Copland, Paul Howard, March 2009


MORE REPORTS >>

Tag Cloud
Archives

Blogroll

American Council on Science and Health
in the Pipeline
Drugwonks
Pharmalot
Reason – Peter Suderman
WSJ Health Blog
The Hill’s Healthwatch
Forbes ScienceBiz
The Apothecary
EyeOnFDA
KevinMD
Marginal Revolution
Megan McArdle
LifeSci VC
Critical Condition
EconLog
In Vivo Blog
PharmaGossip
Pharma Strategy Blog
Drug Discovery Opinion